As new strains of coronavirus appear in various parts of the world and cases within the U.S. continue to peak, officials are stressing the importance of getting vaccinated. 

"Right now the science suggests that the vaccines are still effective against the strains that have been identified but we're in a race," U.S. Surgeon General Jerome Adams told Cheddar.

Adams said the existence of new virus strains is not uncommon, and COVID-19 has mutated nearly 30 times since it was first discovered. However, he noted that mutations do not necessarily mean the virus will become more deadly or contagious.

While the vaccines appear to be holding up against new variants, there is still pressure, according to Adams, to reach "community immunity" before those doses become ineffective. As a result, the Surgeon General said that more has to be done to increase the volume of vaccinations and to speed up the process.

"We need businesses to be advocates for vaccines and to help us spread information about how people can stay healthy, including by getting vaccinated, so we can open up schools, open up restaurants, get back to worship again, get back to doing the things that we were doing in 2019 before we ever heard of this thing called COVID-19," Adams said.

In a report released today by the Office of the Surgeon General, a lack of prevention investments has impacted the overall health of the country and when it comes to COVID-19, in particular, Adams said he thinks businesses can be a line of defense against the virus if they are willing to be more vocal about people maintaining their health.

He said he was aware of the hesitancy many Americans have when it comes to taking the vaccine, partly because of the speed in which it was developed but wants the public to understand that "there were no safety corners cut whatsoever." Adams expressed a fear that misinformation could cause many people to avoid the vaccine altogether.

Vaccine Timeline

Officials planned for 20 million Americans to get vaccinated by the end of 2020, but the straggling rollout only yielded about 2.8 million people who had received a dose by year's end, partly because some hospitals didn't receive enough doses, while others received a surplus. The surgeon general said that in addition to using pharmacies like CVS and Walgreens, the focus should be shifted to all possible avenues to quickly get as many people vaccinated as possible.

"We need to use churches and other sites where people are so that we can quickly get vaccinations into arms," he noted. "And we also need to address vaccine confidence because a vaccine does nothing if a person is unwilling to take it."

For Adams, it's an all-hands-on-deck approach to stomping out COVID-19 and as the Biden administration gears up to take over the White House, he said he hopes to work with the administration, particularly Surgeon General nominee Vivek Murthy, to continue the effort.

"Dr. Murthy and I have worked together for the past three and half years. It's a small group of surgeons general," Adams said. 

"I want us to be successful, and I'm committed to helping the Biden administration and our country — because I am the nation's doctor — really recover from this pandemic. And that's why I put this report out today," he added.

Share:
More In Politics
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More